These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1090 related items for PubMed ID: 8963860

  • 1. Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapy.
    Summanen P, Immonen I, Kivelä T, Tommila P, Heikkonen J, Tarkkanen A.
    Ophthalmic Surg Lasers; 1995; 26(5):449-60. PubMed ID: 8963860
    [Abstract] [Full Text] [Related]

  • 2. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L, Nilsson B, Lundell G, Lundell M, Seregard S.
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
    Bacin F, Kwiatkowski F, Dalens H, Rozan R, Gagyi S, Donnarieix D, Bard JJ, Robert JL.
    J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
    [Abstract] [Full Text] [Related]

  • 5. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F, Roy P, Kodjikian L, Gérard JP, Jean-Louis B, Grange JD.
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plaque brachytherapy for uveal melanoma: a vision prognostication model.
    Khan N, Khan MK, Bena J, Macklis R, Singh AD.
    Int J Radiat Oncol Biol Phys; 2012 Nov 01; 84(3):e285-90. PubMed ID: 22658514
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.
    Summanen P, Immonen I, Kivelä T, Tommila P, Heikkonen J, Tarkkanen A.
    Br J Ophthalmol; 1996 Aug 01; 80(8):732-9. PubMed ID: 8949719
    [Abstract] [Full Text] [Related]

  • 10. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
    Puusaari I, Heikkonen J, Kivelä T.
    Invest Ophthalmol Vis Sci; 2004 Oct 01; 45(10):3425-34. PubMed ID: 15452045
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up after uveal melanoma charged particle therapy.
    Char DH, Kroll SM, Castro J.
    Trans Am Ophthalmol Soc; 1997 Oct 01; 95():171-87; discussion 187-91. PubMed ID: 9440169
    [Abstract] [Full Text] [Related]

  • 12. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P, Kivelä T.
    Ophthalmology; 2006 May 01; 113(5):865-73. PubMed ID: 16530837
    [Abstract] [Full Text] [Related]

  • 13. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J, Monge OR, Skorpen TN, Mørk SJ, Dahl O.
    Eye (Lond); 2008 Nov 01; 22(11):1398-403. PubMed ID: 17585309
    [Abstract] [Full Text] [Related]

  • 14. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients.
    Shields CL, Shields JA, Cater J, Gündüz K, Miyamoto C, Micaily B, Brady LW.
    Arch Ophthalmol; 2000 Sep 01; 118(9):1219-28. PubMed ID: 10980767
    [Abstract] [Full Text] [Related]

  • 15. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.
    Bianciotto C, Shields CL, Pirondini C, Mashayekhi A, Furuta M, Shields JA.
    Ophthalmology; 2010 May 01; 117(5):1005-12. PubMed ID: 20079924
    [Abstract] [Full Text] [Related]

  • 16. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy.
    Summanen P, Immonen I, Heikkonen J, Tommila P, Laatikainen L, Tarkkanen A.
    Ophthalmic Surg; 1993 Feb 01; 24(2):82-90. PubMed ID: 8446359
    [Abstract] [Full Text] [Related]

  • 17. Ruthenium-106 plaque brachytherapy for uveal melanoma.
    Tarmann L, Wackernagel W, Avian A, Mayer C, Schneider M, Winkler P, Langmann G.
    Br J Ophthalmol; 2015 Dec 01; 99(12):1644-9. PubMed ID: 25979763
    [Abstract] [Full Text] [Related]

  • 18. [Oncologic and functional results of 57 malignant melanoma of the uvea treated by curietherapy].
    Bacin F, Albuisson E, Rozan R, Donnarieix D, Verrelle P, Dalens H.
    J Fr Ophtalmol; 1991 Dec 01; 14(6-7):383-96. PubMed ID: 1779110
    [Abstract] [Full Text] [Related]

  • 19. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.
    Aziz HA, Singh N, Bena J, Wilkinson A, Singh AD.
    JAMA Ophthalmol; 2016 Jun 01; 134(6):615-20. PubMed ID: 27101414
    [Abstract] [Full Text] [Related]

  • 20. Ocular complications after iodine brachytherapy for large uveal melanomas.
    Puusaari I, Heikkonen J, Kivelä T.
    Ophthalmology; 2004 Sep 01; 111(9):1768-77. PubMed ID: 15350335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.